172 related articles for article (PubMed ID: 25481638)
1. Can measurement of apparent diffusion coefficient before treatment predict the response to uterine artery embolization for adenomyosis?
Park Y; Kim MD; Jung DC; Lee SJ; Kim G; Park SI; Won JY; Lee DY
Eur Radiol; 2015 May; 25(5):1303-9. PubMed ID: 25481638
[TBL] [Abstract][Full Text] [Related]
2. Apparent diffusion coefficient of uterine leiomyoma as a predictor of the potential response to uterine artery embolization.
Lee MS; Kim MD; Jung DC; Lee M; Won JY; Park SI; Lee DY; Lee KH
J Vasc Interv Radiol; 2013 Sep; 24(9):1361-5. PubMed ID: 23891046
[TBL] [Abstract][Full Text] [Related]
3. Entropy of T2-weighted imaging combined with apparent diffusion coefficient in prediction of uterine leiomyoma volume response after uterine artery embolization.
Cao MQ; Suo ST; Zhang XB; Zhong YC; Zhuang ZG; Cheng JJ; Chi JC; Xu JR
Acad Radiol; 2014 Apr; 21(4):437-44. PubMed ID: 24594413
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MR imaging of uterine leiomyomas following uterine artery embolization.
Sutter O; Soyer P; Shotar E; Dautry R; Guerrache Y; Placé V; Opréa R; Ricbourg A; Le Dref O; Boudiaf M; Sirol M; Dohan A
Eur Radiol; 2016 Oct; 26(10):3558-70. PubMed ID: 26801165
[TBL] [Abstract][Full Text] [Related]
5. Prediction of early response to uterine arterial embolisation of adenomyosis: value of T2 signal intensity ratio of adenomyosis.
Jung DC; Kim MD; Oh YT; Won JY; Lee DY
Eur Radiol; 2012 Sep; 22(9):2044-9. PubMed ID: 22527376
[TBL] [Abstract][Full Text] [Related]
6. Predisposing factors for predicting the therapeutic response of adenomyosis after uterine artery embolization: serum CA125 levels and accompanying endometriosis.
Zheng R; Zeng D; Wan TT; Guo WB; Guo Y; Liu MJ
Diagn Interv Radiol; 2018 Nov; 24(6):364-371. PubMed ID: 30373724
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted imaging in uterine artery embolisation: do findings correlate with contrast enhancement and volume reduction?
Ananthakrishnan G; Macnaught G; Hinksman L; Gilmour H; Forbes KP; Moss JG
Br J Radiol; 2012 Nov; 85(1019):e1046-50. PubMed ID: 22898156
[TBL] [Abstract][Full Text] [Related]
8. Uterine Artery Embolization for Symptomatic Adenomyosis: 7-Year Clinical Follow-up Using UFS-Qol Questionnaire.
de Bruijn AM; Smink M; Hehenkamp WJK; Nijenhuis RJ; Smeets AJ; Boekkooi F; Reuwer PJHM; Van Rooij WJ; Lohle PNM
Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1344-1350. PubMed ID: 28516272
[TBL] [Abstract][Full Text] [Related]
9. Outcome prediction for symptomatic patients with fibroids who underwent uterine artery embolization.
Wu Q; Motaghi M; Tang H; Hazhirkarzar B; Shaghaghi M; Ghadimi M; Baghdadi A; Rezvani R; Mohseni A; Borhani A; Madani SP; Afyouni S; Zandieh G; Kamel IR
Clin Imaging; 2024 Jan; 105():110028. PubMed ID: 38039750
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted imaging for evaluation of uterine arterial embolization of fibroids.
Faye N; Pellerin O; Thiam R; Chammings F; Brisa M; Marques E; Cuénod CA; Sapoval M; Fournier LS
Magn Reson Med; 2013 Dec; 70(6):1739-47. PubMed ID: 23440651
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of uterine artery embolization as a nonsurgical treatment option for adenomyosis.
Wang S; Meng X; Dong Y
Int J Gynaecol Obstet; 2016 May; 133(2):202-5. PubMed ID: 26868068
[TBL] [Abstract][Full Text] [Related]
12. Unique Learning System for Uterine Artery Embolization for Symptomatic Myoma and Adenomyosis for Obstetrician-Gynecologists in Cooperation with Interventional Radiologists: Evaluation of UAE From the Point of View of Gynecologists Who Perform UAE.
Soeda S; Hiraiwa T; Takata M; Kamo N; Sekino H; Nomura S; Kojima M; Kyozuka H; Ozeki T; Ishii S; Tameda T; Asano K; Miyazaki M; Takahashi T; Watanabe T; Taki Y; Fujimori K
J Minim Invasive Gynecol; 2018 Jan; 25(1):84-92. PubMed ID: 28807810
[TBL] [Abstract][Full Text] [Related]
13. Uterine artery embolization for symptomatic adenomyosis: a new technical development of the 1-2-3 protocol and predictive factors of MR imaging affecting outcomes.
Kim MD; Kim YM; Kim HC; Cho JH; Kang HG; Lee C; Kim HJ; Lee JT
J Vasc Interv Radiol; 2011 Apr; 22(4):497-502. PubMed ID: 21377897
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of uterine artery embolization for symptomatic adenomyosis.
Smeets AJ; Nijenhuis RJ; Boekkooi PF; Vervest HA; van Rooij WJ; Lohle PN
Cardiovasc Intervent Radiol; 2012 Aug; 35(4):815-9. PubMed ID: 21717251
[TBL] [Abstract][Full Text] [Related]
15. Uterine artery embolization to treat uterine adenomyosis with or without uterine leiomyomata: results of symptom control and health-related quality of life 40 months after treatment.
Froeling V; Scheurig-Muenkler C; Hamm B; Kroencke TJ
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):523-9. PubMed ID: 21850565
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted imaging (DWI) of adenomyosis and fibroids of the uterus.
Jha RC; Zanello PA; Ascher SM; Rajan S
Abdom Imaging; 2014 Jun; 39(3):562-9. PubMed ID: 24531353
[TBL] [Abstract][Full Text] [Related]
17. Uterine Artery Embolization for Adenomyosis: Percentage of Necrosis Predicts Midterm Clinical Recurrence.
Bae SH; Kim MD; Kim GM; Lee SJ; Park SI; Won JY; Lee DY
J Vasc Interv Radiol; 2015 Sep; 26(9):1290-6.e2. PubMed ID: 26074028
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of uterine artery embolization for symptomatic adenomyosis.
Kim MD; Kim S; Kim NK; Lee MH; Ahn EH; Kim HJ; Cho JH; Cha SH
AJR Am J Roentgenol; 2007 Jan; 188(1):176-81. PubMed ID: 17179361
[TBL] [Abstract][Full Text] [Related]
19. Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study.
Jalaguier-Coudray A; Villard-Mahjoub R; Delouche A; Delarbre B; Lambaudie E; Houvenaeghel G; Minsat M; Tallet A; Sabatier R; Thomassin-Naggara I
Radiology; 2017 Aug; 284(2):432-442. PubMed ID: 28301309
[TBL] [Abstract][Full Text] [Related]
20. Uterine artery embolization for symptomatic adenomyosis with or without uterine leiomyomas with the use of calibrated tris-acryl gelatin microspheres: midterm clinical and MR imaging follow-up.
Lohle PN; De Vries J; Klazen CA; Boekkooi PF; Vervest HA; Smeets AJ; Lampmann LE; Kroencke TJ
J Vasc Interv Radiol; 2007 Jul; 18(7):835-41. PubMed ID: 17609441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
